Literature DB >> 17148506

Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells.

Faiy H Psahoulia1, Sophy Moumtzi, Michael L Roberts, Takehiko Sasazuki, Senji Shirasawa, Alexander Pintzas.   

Abstract

Several food polyphenols act as chemopreventers by reducing the incidence of many types of cancer, especially in colon epithelia. In this study, we have investigated whether the flavonoid quercetin can modulate cell proliferation and survival by targeting key molecules and/or biological processes responsible for tumor cell properties. The effect of quercetin on the expression of Ras oncoproteins was specifically studied using systems of either constitutive or conditional expression of oncogenic RAS in human epithelial cells. Our findings suggest that quercetin inhibits cell viability as well as cancer cell properties like anchorage-independent growth. These findings were further supported at the molecular level, since quercetin treatment resulted in a preferential reduction of Ras protein levels in cell lines expressing oncogenic Ras proteins. Notably, in cells that only express wild-type Ras or in those where the oncogenic Ras allele was knocked out, quercetin had no evident effects upon Ras levels. We have shown that quercetin drastically reduces half-life of oncogenic Ras but has no effect when the cells are treated with a proteasome inhibitor. Moreover, in Ha-RAS-transformed cells, quercetin induces autophagic processes. Since quercetin downregulates the levels of oncogenic Ras in cancer cells, we propose that this flavonoid could act as a chemopreventive agent for cancers with frequent mutations of RAS genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17148506     DOI: 10.1093/carcin/bgl232

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  29 in total

1.  A study of quercetin effects on phospholipid membranes containing cholesterol using Laurdan fluorescence.

Authors:  Diana Ionescu; Constanţa Ganea
Journal:  Eur Biophys J       Date:  2012-02-03       Impact factor: 1.733

2.  The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.

Authors:  Angélica Maria Sabogal-Guáqueta; Juan Ignacio Muñoz-Manco; Jose R Ramírez-Pineda; Marisol Lamprea-Rodriguez; Edison Osorio; Gloria Patricia Cardona-Gómez
Journal:  Neuropharmacology       Date:  2015-02-07       Impact factor: 5.250

Review 3.  A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer.

Authors:  Atousa Haghi; Haniye Azimi; Roja Rahimi
Journal:  J Gastrointest Cancer       Date:  2017-12

Review 4.  Plant natural products: from traditional compounds to new emerging drugs in cancer therapy.

Authors:  L Ouyang; Y Luo; M Tian; S-Y Zhang; R Lu; J-H Wang; R Kasimu; X Li
Journal:  Cell Prolif       Date:  2014-12       Impact factor: 6.831

5.  Autophagic activity dictates the cellular response to oncogenic RAS.

Authors:  Yihua Wang; Xiao Dan Wang; Eleonora Lapi; Alexandra Sullivan; Wei Jia; You-Wen He; Indrika Ratnayaka; Shan Zhong; Robert D Goldin; Christoph G Goemans; Aviva M Tolkovsky; Xin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

6.  Quercetin may suppress rat aberrant crypt foci formation by suppressing inflammatory mediators that influence proliferation and apoptosis.

Authors:  Cynthia A Warren; Kimberly J Paulhill; Laurie A Davidson; Joanne R Lupton; Stella S Taddeo; Mee Young Hong; Raymond J Carroll; Robert S Chapkin; Nancy D Turner
Journal:  J Nutr       Date:  2008-12-03       Impact factor: 4.798

Review 7.  Macroautophagy: the key ingredient to a healthy diet?

Authors:  Adrienne M Hannigan; Sharon M Gorski
Journal:  Autophagy       Date:  2009-02-03       Impact factor: 16.016

8.  The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo.

Authors:  Eliane Angst; Jenny L Park; Aune Moro; Qing-Yi Lu; Xuyang Lu; Gang Li; Jonathan King; Monica Chen; Howard A Reber; Vay Liang W Go; Guido Eibl; Oscar J Hines
Journal:  Pancreas       Date:  2013-03       Impact factor: 3.327

9.  Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation.

Authors:  Kathleen A Boyle; Jonathan Van Wickle; R Blake Hill; Adriano Marchese; Balaraman Kalyanaraman; Michael B Dwinell
Journal:  J Biol Chem       Date:  2018-08-07       Impact factor: 5.157

Review 10.  Autophagy in colorectal cancer: An important switch from physiology to pathology.

Authors:  Florin Burada; Elena Raluca Nicoli; Marius Eugen Ciurea; Daniel Constantin Uscatu; Mihai Ioana; Dan Ionut Gheonea
Journal:  World J Gastrointest Oncol       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.